Pfizer's controversial 'tax inversion' of Allergan is likely to close despite bipartisan annoyance at the deal, which will deprive the US Treasury of billions of dollars in taxes over the next few years. It is too late for Congress to pass legislation to prevent such deals before the 2016 presidential election. While the government has the authority to implement retroactive changes to the rules...
Complete the trial form to receive a free issue of Corporate Financing Week sent to your email address. Giving you analysis of the latest corporate financing trends and deals
START A FREE TRIAL TODAY
STEP 2: SELECT PRODUCTS
Please select the free products you would like to trial:
Thank you for your interest in Corporate Financing Week
You will shortly receive an e-mail with link(s) to a full version of the newsletter(s) you selected. A member of our Client Services team will be in touch soon to receive your feedback on the newsletters and arrange a convenient time for a free demonstration of the full service. If your enquiry is urgent, please email our team here Thanks, BMI Research